IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 37 filers reported holding IRADIMED CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $908,520 | -54.2% | 20,476 | -50.7% | 0.18% | -52.4% |
| Q2 2023 | $1,984,456 | -41.9% | 41,568 | -45.4% | 0.37% | -42.1% |
| Q1 2022 | $3,416,000 | +60.1% | 76,179 | +64.9% | 0.64% | +81.7% |
| Q4 2021 | $2,134,000 | +33.6% | 46,186 | -2.9% | 0.35% | +29.6% |
| Q3 2021 | $1,597,000 | +134.2% | 47,547 | +96.0% | 0.27% | +61.7% |
| Q1 2019 | $682,000 | -60.1% | 24,263 | -65.3% | 0.17% | -64.0% |
| Q4 2018 | $1,709,000 | -24.8% | 69,850 | +14.1% | 0.46% | +37.3% |
| Q3 2018 | $2,274,000 | +198.0% | 61,207 | +66.4% | 0.34% | +181.7% |
| Q2 2018 | $763,000 | +83.9% | 36,774 | +25.0% | 0.12% | +73.9% |
| Q1 2018 | $415,000 | -9.2% | 29,426 | -2.4% | 0.07% | -15.9% |
| Q4 2017 | $457,000 | -79.3% | 30,141 | -61.8% | 0.08% | -71.6% |
| Q4 2015 | $2,213,000 | +15.5% | 78,945 | +0.4% | 0.29% | -4.6% |
| Q3 2015 | $1,916,000 | +5.4% | 78,634 | +0.7% | 0.30% | +42.3% |
| Q2 2015 | $1,818,000 | – | 78,105 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 783,066 | $30,814,000 | 5.13% |
| Soleus Capital Management, L.P. | 773,694 | $30,444,859 | 3.15% |
| RK Capital | 335,400 | $13,197,990 | 2.90% |
| Capital Impact Advisors, LLC | 19,390 | $762,997 | 0.94% |
| Ranger Investment Management | 205,692 | $8,093,980 | 0.54% |
| Bares Capital Management | 317,000 | $12,473,950 | 0.44% |
| Hillsdale Investment Management Inc. | 109,100 | $4,293,085 | 0.37% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,007 | $1,456,225 | 0.26% |
| Riverwater Partners LLC | 6,234 | $245,308 | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 72,271 | $2,843,864 | 0.16% |